Comparison of ivermectin and albendazole treatment for gnathostomiasis

Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):374-7.

Abstract

Comparative treatment of ivermectin in 21 patients (Group 1) and albendazole in 49 patients (Group 2) of gnathostomiasis gave the cure at 95.2% and 93.8% respectively. The ELISA OD and eosinophil counts were reduction after treatment. Side effects in ivermectin were hypotention, dizziness, weakness and diuresis; and side effects of albendazole were nausia, dizziness and increased alkaline phosphatase in two cases. Ivermectin should be an effective drug againts gnathostomiasis and more convenient in treatment single dose.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Albendazole / adverse effects
  • Albendazole / therapeutic use*
  • Animals
  • Antinematodal Agents / adverse effects
  • Antinematodal Agents / therapeutic use*
  • Child
  • Eosinophils
  • Female
  • Gnathostoma*
  • Humans
  • Ivermectin / adverse effects
  • Ivermectin / therapeutic use*
  • Leukocyte Count
  • Male
  • Middle Aged
  • Spirurida Infections / drug therapy*

Substances

  • Antinematodal Agents
  • Ivermectin
  • Albendazole